Transmedics group, inc. (TMDX)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18
Assets
Current assets:
Cash and cash equivalents

24,738

20,092

20,407

47,242

12,215

20,241

Marketable Securities

47,816

60,596

67,865

48,995

-

-

Accounts receivable

6,133

6,559

6,465

7,105

5,146

3,438

Inventory

11,361

11,216

10,536

11,220

11,294

9,277

Prepaid expenses and other current assets

1,656

1,538

2,093

1,571

1,404

1,838

Total current assets

91,704

100,001

107,366

116,133

30,059

34,794

Property and equipment, net

4,713

4,792

4,746

4,375

3,750

3,474

Deferred offering costs

-

-

-

-

4,444

3,383

Restricted cash

500

500

500

500

500

500

Other long-term assets

6

6

6

6

6

6

Total assets

96,923

105,299

112,618

121,014

38,759

42,157

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

4,860

7,247

4,766

6,662

5,499

4,720

Accrued expenses and other current liabilities

9,926

8,332

9,348

8,180

9,989

7,178

Deferred revenue

164

166

162

175

359

306

Current portion of deferred rent

89

370

365

360

354

349

Total current liabilities

15,039

16,115

14,641

15,377

16,201

12,553

Preferred stock warrant liability

-

-

-

-

625

898

Long-term debt, net of discount and current portion

34,269

34,146

34,023

33,902

33,785

33,670

Deferred rent, net of current portion

932

389

482

574

667

759

Total liabilities

50,240

50,650

49,146

49,853

51,278

47,880

Convertible preferred stock (Series A-1, B, B-1, C, D, E and F) $0.0001 par value; no shares and 50,776,054 shares authorized at December 28, 2019 and December 29, 2018, respectively; and no shares and 50,404,140 shares issued and outstanding at December 28, 2019 and December 29, 2018, respectively

-

-

-

-

186,519

186,519

Stockholders' deficit:
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding

0

0

-

-

-

-

Common stock, no par value; 150,000,000 shares and no shares authorized at December 28, 2019 and December 29, 2018, respectively; 21,184,524 shares and no shares issued and outstanding at December 28, 2019 and December 29, 2018, respectively

424,791

424,134

423,758

423,245

1

1

Additional paid-in capital

-

-

-

-

143,859

143,794

Accumulated other comprehensive income (loss)

227

-2

20

-58

-67

-101

Accumulated deficit

-378,335

-369,483

-360,306

-352,026

-342,831

-335,936

Total stockholders' equity

46,683

54,649

63,472

71,161

-199,038

-192,242

Total liabilities and stockholders' equity

96,923

105,299

112,618

121,014

38,759

42,157